Table 1: Demographic features and biochemical characteristics of HCC and liver cirrhosis patients.

Characteristics HCC Group (N = 40) Liver Cirrhosis Group (N = 30) P Value
Age (years) 60.92 ± 9.01 55.53 ± 9.64 0.02*
Gender Male Female 31 (77.5%) 9 (22.5%) 15 (50%) 15 (50%) 0.02*
Residence Urban Rural 25 (62.5%) 15 (37.5%) 20 (66.67%) 10 (33.33%) 0.72
Occupation Farmer Non- farmer 14 (35%) 26 (65%) 4 (13.33%) 26 (86.67%) 0.04*
Etiology Smoking Alcohol HCV HBV 22 (55%) 1 (2.5%) 37 (92.5%) 2 (5%) 11 (36.67%) 0 (0%) 22 (73.33%) 1 (3.33%) 0.13 1 0.04* 1
ALT (IU) 34.97 (2.9-160) 14.8 (19-87) 0.000*
AST(IU) 36.2 (28-137) 12.7 (24-75) 0.000*
ALP (IU) 174.95 ± 121.36 167.17 ± 121.3 0.22
Total Bilirubin mg/dl 3.19 (0.6- 63) 1.95 (0.5- 21) 0.07
Albumin g/dl 2.62 ± 0.55 2.5 ± 0.77 0.45
PT (seconds) 17.29 ± 4.54 18.69 ± 10.9 0.56
INR 1.46 ± 0.31 1.6 ± 0.94 0.77
Creatinine mg/dl 2.12 ± 1.72 1.73 ± 1.3 0.33

SD: Standard deviation; HCC: hepatocellular carcinoma; MELD: Model for end stage liver disease; uMELD: updated MELD.
Data are presented as mean ± standard deviation or median with minimum and maximum values, as appropriate. HCC: hepatocellular carcinoma; HCV: Hepatitis c virus; HBV: Hepatitis B virus; ALT:Alanine aminotransferase; AST:aspartate aminotransferase; ALP:alkaline phosphatase; PT:prothrombin time; INR:international normalized ratio *:Values statistically significant (at P< 0.05).